"Horisont 2020 programm" projekt MP1GI18503R
MP1GI18503R "European Advanced infraStructure for Innovative Genomics (1.02.2019−31.01.2023)", Tõnu Esko, Tartu Ülikool, Tartu Ülikooli genoomika instituut.
824110
MP1GI18503R
European Advanced infraStructure for Innovative Genomics
European Advanced infraStructure for Innovative Genomics
EASI-Genomics
1.02.2019
31.01.2023
Teadus- ja arendusprojekt
Horisont 2020 programm
ETIS klassifikaatorAlamvaldkondCERCS klassifikaatorFrascati Manual’i klassifikaatorProtsent
1. Bio- ja keskkonnateadused1.3. GeneetikaB220 Geneetika, tsütogeneetika 1.6 Bioteadused33,0
3. Terviseuuringud3.1. BiomeditsiinB726 Kliiniline bioloogia 3.1 Biomeditsiin33,0
4. Loodusteadused ja tehnika4.16. Biotehnoloogia (loodusteadused ja tehnika)T490 Biotehnoloogia 2.7 Keskkonnatehnika34,0
AsutusRiikTüüp
Euroopa Komisjon
PerioodSumma
01.02.2019−31.01.2023410 489,00 EUR
410 489,00 EUR

Next-generation sequencing (NGS) has taken modern research by storm and consequently is one of the most important tools of modern biological and biomedical research. However, the high cost of instrumentation and reagents, the multifaceted expertise required for correct use and the legal and ethical issues hamper access to NGS technologies for many researchers. EASI-Genomics addresses those challenges by unifying the major European genome centers that provide external access to their facilities. The mission of EASI-Genomics is to facilitate access to cutting-edge DNA sequencing technologies to researchers from both academia and industry, within a framework that ensures compliance with ethical and legal requirements, as well as FAIR and secure data management. EASI-Genomics will provide fully funded access to more than 150 transnational access projects, selected through public calls and a rigorous, fair and transparent peer-review process. Each funded study will be supported from design, through sequencing, to data analysis. EASIGenomics will provide more than 100 Tb of sequence and more than 25,000 hours of bioinformatic, analytical and data management support to the user community. As outlined in the call, EASI-Genomics will provide access to advanced methods that go beyond what is commercially available. The focus will be on more complex procedures involving shortreads, long-reads, in situ sequencing and single-cell analysis. Complex integrative projects and projects on non-human samples will also be highlighted. Finally, EASI-Genomics will support the wider NGS community to improve their quality control processes by offering open inter-laboratory comparisons allowing them to obtain ISO certification and accreditation in line with many of the EASI-Genomic partners. The EASI-Genomics project aims to build a community of practice, which leverages advanced sequencing technologies beyond country and sector borders to tackle global challenges in science.
KirjeldusProtsent
Alusuuring50,0
Rakendusuuring50,0
AsutusRollRiikTüüpKommentaar
CHARITE - UNIVERSITAETSMEDIZIN BERLINpartnerSaksamaa Liitvabariik
CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIELpartnerSaksamaa Liitvabariikülikool
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVESpartnerPrantsuse VabariikTA asutus
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERGpartnerSaksamaa LiitvabariikTA asutus
EUROPEAN MOLECULAR BIOLOGY LABORATORYpartnerSaksamaa Liitvabariik
FUNDACIO CENTRE DE REGULACIO GENOMICAkoordinaatorHispaania KuningriikTA asutus
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALEpartnerPrantsuse VabariikTA asutus
KATHOLIEKE UNIVERSITEIT LEUVENpartnerBelgia Kuningriikülikool
KUNGLIGA TEKNISKA HOEGSKOLANpartnerRootsi Kuningriikülikool
LGC LIMITEDpartnerSuurbritannia ja Põhja-Iiri Ühendkuningriikettevõte
MAX-DELBRUCK-CENTRUM FUR MOLEKULAREMEDIZINpartnerSaksamaa LiitvabariikTA asutus
MEDIZINISCHE UNIVERSITAT GRAZpartnerAustria Vabariikülikool
QIAGEN GMBHpartnerSaksamaa Liitvabariikettevõte
STOCKHOLMS UNIVERSITETpartnerRootsi Kuningriikülikool
UPPSALA UNIVERSITETpartnerRootsi Kuningriikülikool